Enhanced pro-inflammatory cytokine production (IL-21/IL-22) on PBMC in AU. Decreased anti-inflammatory molecules (IL-27/CTLA-4) on PBMC in AU. Induction of IL-21/IL-22 protein and mRNA expression in AU children. Decreased IL-27 mRNA expression in children with AU.